PRIYA MATHUR: Open Payments
NPI 1124763669 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,861 in 143 payments from 44 companies in 2025. Trend: 2023 $2,835 · 2024 $3,887 · 2025 $3,861
Food & beverage: $3,100Long term medical supply or device loan: $682Education: $80
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 23 | $1,037 |
| Janssen Biotech, Inc. | 13 | $424 |
| ABBVIE INC. | 15 | $270 |
| Merck Sharp & Dohme LLC | 6 | $177 |
| Regeneron Healthcare Solutions, Inc. | 5 | $121 |
| ARRAY BIOPHARMA INC | 8 | $114 |
| Genentech USA, Inc. | 5 | $99 |
| GlaxoSmithKline, LLC. | 4 | $98 |
| TerSera Therapeutics LLC | 3 | $91 |
| TAIHO ONCOLOGY, INC. | 3 | $77 |
Products named: KISQALI, ERLEADA, KEYTRUDA, RYBREVANT, LIBTAYO, VENCLEXTA, OJJAARA, Enhertu.
Industry payments across NC — which companies pay providers there.
